Evidence map›Paper›PMID 38598298›Full record

ArticleMolecular biology of the cell2024

TGFβ overcomes FGF-induced transinhibition of EGFR in lens cells to enable fibrotic secondary cataract.

Judy K VanSlyke, Bruce A Boswell, Linda S Musil

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Judy K VanSlykeDepartment of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR 97239.
Bruce A BoswellDepartment of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR 97239.
Linda S MusilDepartment of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR 97239.

Funding

Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Kate E Keller · 1995 to 2026
$19.4M
New strategies for prevention of posterior capsule opacificationR01EY028558 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI MUSIL, LINDA S · 2018 to 2022
$1.9M
NEI NIH HHS P30 EY010572NEI NIH HHS R01 EY028558
6 · The paper itself

Abstract

To cause vision-disrupting fibrotic secondary cataract (PCO), lens epithelial cells that survive cataract surgery must migrate to the posterior of the lens capsule and differentiate into myofibroblasts. During this process, the cells become exposed to the FGF that diffuses out of the vitreous body. In normal development, such relatively high levels of FGF induce lens epithelial cells to differentiate into lens fiber cells. It has been a mystery as to how lens cells could instead undergo a mutually exclusive cell fate, namely epithelial to myofibroblast transition, in the FGF-rich environment of the posterior capsule. We and others have reported that the ability of TGFβ to induce lens cell fibrosis requires the activity of endogenous ErbBs. We show here that lens fiber-promoting levels of FGF induce desensitization of ErbB1 (EGFR) that involves its phosphorylation on threonine 669 mediated by both ERK and p38 activity. Transinhibition of ErbB1 by FGF is overcome by a time-dependent increase in ErbB1 levels induced by TGFβ, the activation of which is increased after cataract surgery. Our studies provide a rationale for why TGFβ upregulates ErbB1 in lens cells and further support the receptor as a therapeutic target for PCO.

Indexed as

CataractEpithelial CellsErbB ReceptorsFibrosisLens, CrystallineTransforming Growth Factor betaFibroblast Growth FactorsHumansMyofibroblastsp38 Mitogen-Activated Protein KinasesPhosphorylationSignal TransductionEGFR protein, humanErbB ReceptorsFibroblast Growth Factorsp38 Mitogen-Activated Protein KinasesTransforming Growth Factor beta

Identifiers

PMID38598298
PMCPMC11238076

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.